VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,187,000 | +92.7% | 6,652 | +139.7% | 0.49% | +111.7% |
| Q2 2015 | $616,000 | +11.8% | 2,775 | 0.0% | 0.23% | +13.9% |
| Q1 2015 | $551,000 | +38.8% | 2,775 | 0.0% | 0.20% | +36.5% |
| Q4 2014 | $397,000 | +6.1% | 2,775 | -2.6% | 0.15% | +5.0% |
| Q3 2014 | $374,000 | -4.3% | 2,850 | -8.1% | 0.14% | -7.8% |
| Q2 2014 | $391,000 | -99.9% | 3,100 | -8.6% | 0.15% | -19.0% |
| Q1 2014 | $446,904,000 | +39240.1% | 3,390 | -65.0% | 0.19% | -60.5% |
| Q4 2013 | $1,136,000 | – | 9,675 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |